Publications
“It is beyond a doubt that all our knowledge begins with experience.” – Immanuel Kant
Melior Capital Management
PRESS RELEASE
Melior Insights – Q1 2020
A BRIEF REVIEW OF 2019 LIFE SCIENCE M&A ACTIVITY
What to expect in 2020?
BIG PHARMA PURSUIT OF NEW REVENUE STREAMSTHROUGH M&A
The case study of Eli Lilly.
FDA’S NEW DRUG APPLICATIONS APPROVED LIST
What is the focus of pharma companies?
Melior Insights – Special Report: COVID-19
IS THERE A SOLUTION FOR COVID-19?
The view of a life science professional with 40+ years of experience
LIFE SCIENCE MARKET FINANCIALS
What are the numbers telling us about the effects of COVID-19?
HOW ARE REGULATORY AGENCIES REACTING TO COVID-19?
The case study of the Food and Drug Administration (FDA)
THE LIFE SCIENCE INDUSTRY IN THE COVID-19 EPOCH
Critical questions for companies and investors
Melior Insights – May 2020
ARE WE ON THE VERGE OF A LIVER PANDEMIC?
A compelling story about life science investments
THE LIVER – THE LARGEST AND HEAVIEST INTERNAL ORGAN
One of the key organs with a long list of functions and roles
THE ECONOMICS OF LIVER DYSFUNCTION
How much does it cost us?
THE R&D INVESTMENTS FOCUSED ON LIVER DISEASE
Who is leading research and development in liver disease?
Melior Insights – June 2020
AN UNSPOKEN FEMALE HEALTH CARE CRISIS
A critical issue affecting millions, yet often ignored
STRESS URINARY INCONTINENCE (SUI)
A debilitating condition limiting the lives of millions of women
IS THERE A BETTER A WAY TO MANAGE SUI?
The revolutionary device that can give women back control of their life
Melior Insights – July 2020
THE LATEST THINKING ON LIFE SCIENCE INVESTMENTS
What makes life science so attractive to many investors
FIVE DRUGS THAT ARE SET TO BRING TENS OF BILLIONS IN SALES
The stories behind the future blockbuster drugs entering the market in 2020
FIVE MEDICAL DEVICE UPSTARTS TO WATCH
Companies that revolutionise medtech, will save lives and create investor value
COMPANIONS: PHARMACEUTICALS AND MEDICAL DEVICES
Two life science components
Melior Insights – August 2020
THE IMPORTANCE OF THE CARDIOVASCULAR SYSTEM
The functions of the cardiovascular system and conditions affecting it
THE ECONOMICS OF TREATING CARDIOVASCULAR CONDITIONS
What treatments are there and how much do they cost? A focus on cardiovascular devices.
THE DYNAMICS OF THE CARDIOLOGY MARKET
M&A, VC funding and IPOs of cardiology device companies
Melior Insights – September 2020
THE CURRENT STATE OF GLOBAL MARKETS
Are Private Equity investments the solution for generating exceptional returns?
M&A ACTIVITY IN THE FIRST 9 MONTHS OF 2020
What is the state of play in the context of “COVID-19”?
THE OUTLOOK FOR THE EUROPEAN M&A MARKET
Where are we going?
WHAT TO EXPECT FOR LIFE SCIENCE?
One of the most promising sectors in the current environment
Melior Insights – October 2020
LIFE SCIENCE IS TODAY MORE RELEVANT THAN EVER
What are the drivers boosting the importance of this vital sector?
GLOBAL HEALTHCARE FUNDING HITTING A NEW RECORD IN Q3
What is driving the market of venture investments and where is it going?
INVESTORS THINKING REGARDING PRIVATE DEALS
What is driving the market and where is it going?
Melior Insights – February 2021
THE GLOBAL ECONOMY DURING 2020
The consequential effects of the pandemic
THE LIFE SCIENCE SECTOR IN 2020
What is driving the market of venture investments and where is it going?
WHAT TO EXPECT IN 2021 FOR LIFE SCIENCE?
The future is now… the need is there
Melior Insights – April 2021
THE DNA OF HEALTHCARE AND LIFE SCIENCE IS CHANGING… AND IT’S CHANGING FOR THE BETTER.
What are the forces that are shaping this change?
Melior Insights – August 2021
THE HEART IMPLANT TREATING ATRIAL FIBRILLATION
A REVOLUTIONARY TREATMENT FOR SEVERE KIDNEY DISEASE
A SAFER WAY TO PREVENTING PULMONARY EMBOLISM
Melior Insights – October 2021
THE GROWING ROLE OF MEDTECH IN GLOBAL HEALTH
MEDTECH TRENDS
MEDTECH PRIVATE INVESTMENTS
MEDTECH M&A
MEDTECH IPOS
Melior Insights – February 2022
MEDTECH VENTURE CAPITAL INVESTMENTS
MEDTECH MERGERS AND ACQUISITIONS
WHAT WILL 2022 BRING TO MEDTECH